181 results on '"Zisman, David A"'
Search Results
2. Safety and tolerability of inhaled treprostinil with phosphodiesterase-5 inhibitors in patients with pulmonary hypertension due to interstitial lung disease
3. Utility of Transbronchial vs Surgical Lung Biopsy in the Diagnosis of Suspected Fibrotic Interstitial Lung Disease
4. CHYLOTHORAX SECONDARY TO TUNNELED-CATHETER-INDUCED SUPERIOR VENA CAVA OBSTRUCTION.
5. SCREENING FOR PULMONARY HYPERTENSION IN PATIENTS WITH INTERSTITIAL LUNG DISEASE: RECOMMENDATIONS FROM A DELPHI CONSENSUS PANEL
6. Serum Albumin Concentration and Waiting List Mortality in Idiopathic Interstitial Pneumonia
7. Sildenafil Improves Walk Distance in Idiopathic Pulmonary Fibrosis
8. Idiopathic Pulmonary Fibrosis: Pathogenesis and Therapeutic Approaches
9. Sildenafil in Idiopathic Pulmonary Fibrosis
10. Corticosteroid Therapy for Sarcoidosis
11. Diagnosis and Hemodynamic Assessment of Pulmonary Arterial Hypertension
12. Pulmonary Fibrosis
13. Idiopathic Pulmonary Fibrosis: A Shot through the Heart?
14. Response
15. Validation of a Method To Screen for Pulmonary Hypertension in Advanced Idiopathic Pulmonary Fibrosis*
16. Role of High-Resolution Thin Section Computed Tomographic Scanning
17. Acute Exacerbations of Idiopathic Pulmonary Fibrosis
18. High-Resolution Chest CT Findings Do Not Predict the Presence of Pulmonary Hypertension in Advanced Idiopathic Pulmonary Fibrosis*
19. Role for Transbronchial Biopsy in the Diagnosis of Usual Interstitial Pneumonia
20. Retrospective Study of Pulmonary Function Tests in Patients Presenting With Isolated Reduction in Single-Breath Diffusion Capacity: Implications for the Diagnosis of Combined Obstructive and Restrictive Lung Disease
21. Usual Interstitial Pneumonia
22. Transbronchial Biopsy and Usual Interstitial Pneumonia: A Step Forward in Disease Management
23. Transbronchial Biopsy in Usual Interstitial Pneumonia*
24. CXCL11 Attenuates Bleomycin-induced Pulmonary Fibrosis via Inhibition of Vascular Remodeling
25. Association Between Pulmonary Fibrosis and Coronary Artery Disease
26. Echocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease
27. Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome
28. Sarcoidosis Involving the Musculoskeletal System
29. DONOR RACE AND GENDER ARE INDEPENDENTLY ASSOCIATED WITH DEVELOPMENT OF PRIMARY GRAFT FAILURE FOLLOWING LUNG TRANSPLANTATION
30. Cyclophosphamide in the Treatment of Idiopathic Pulmonary Fibrosis*: A Prospective Study in Patients Who Failed To Respond to Corticosteroids
31. MCP-1 Protects Mice in Lethal Endotoxemia
32. Role for transbronchial biopsy in the diagnosis of usual interstitial pneumonia
33. A Single Center, Prospective, Open-Label,Pilot Study, Evaluating The Safety And Efficacy Of IV/SQ Treprostinil In The Treatment Of Pulmonary Hypertension Associated With Advanced Intersitial Lung Disease
34. The STEP-IPF Trial: Sildenafil Trial Of Exercise Performance In Idiopathic Pulmonary Fibrosis
35. Treprostinil to Reverse Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis as a Bridge to Single-Lung Transplantation
36. Idiopathic Pulmonary Fibrosis
37. Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis
38. Utility of CT for Predicting Pulmonary Hypertension in Patients With Parenchymal Lung Disease: Response
39. Idiopathic pulmonary fibrosis
40. VASOREACTIVITY WITH INHALED NITRIC OXIDE AND 100% OXYGEN IN PATIENT'S WITH IDIOPATHIC PULMONARY FIBROSIS AND PULMONARY ARTERIAL HYPERTENSION
41. Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis
42. ECHOCARDIOGRAPHY AS A PREDICTOR OF PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
43. HIGH-RESOLUTION CHEST COMPUTED TOMOGRAPHY FINDINGS DO NOT PREDICT THE PRESENCE OF PULMONARY HYPERTENSION IN ADVANCED IDIOPATHIC PULMONARY FIBROSIS
44. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease
45. IL-13 Is Pivotal in the Fibro-Obliterative Process of Bronchiolitis Obliterans Syndrome
46. Response
47. CXCR2/CXCR2 Ligand Biology during Lung Transplant Ischemia-Reperfusion Injury
48. Rates and Characteristics of Serious Adverse Events (SAEs) in 210 Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Interferon-Gamma 1b (IFN-gamma 1b) in an Open-Label Study
49. Idiopathic Pulmonary Fibrosis
50. Role of CXCL9/CXCR3 Chemokine Biology during Pathogenesis of Acute Lung Allograft Rejection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.